2021 annual financial data
BioMarin Pharmaceutical 2021 Operating margin
Direct answer
Operating margin was -4.46%.
Operating income was -82,341,000 USD and net income was -64,080,000 USD.
Operating cash flow was 304,536,000 USD.
Get free BioMarin Pharmaceutical email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 1,846,275,000 USD
- Operating income
- -82,341,000 USD
- Net income
- -64,080,000 USD
- Operating cash flow
- 304,536,000 USD